Invention Grant
- Patent Title: Methods of inducing immune tolerance to clotting factors
-
Application No.: US16464105Application Date: 2017-12-01
-
Publication No.: US12257288B2Publication Date: 2025-03-25
- Inventor: Jennifer Dumont , Nisha Jain , Stefan Lethagen
- Applicant: BIOVERATIV THERAPEUTICS INC. , SWEDISH ORPHAN BIOVITRUM AB
- Applicant Address: US MA Waltham; SE Stockholm
- Assignee: BIOVERATIV THERAPEUTICS INC.,SWEDISH ORPHAN BIOVITRUM AB
- Current Assignee: BIOVERATIV THERAPEUTICS INC.,SWEDISH ORPHAN BIOVITRUM AB
- Current Assignee Address: US MA Waltham; SE Stockholm
- Agency: LATHROP GPM LLP
- Agent James H. Velema, Esq.; James V. DeGiulio, Esq.
- International Application: PCT/US2017/064323 WO 20171201
- International Announcement: WO2018/102760 WO 20180607
- Main IPC: A61K38/37
- IPC: A61K38/37 ; A61K38/48 ; A61P7/04
Abstract:
The present disclosure provides methods inducing immune tolerance in a human, comprising administering to the human an effective amount of a composition or a chimeric protein comprising a clotting factor and an Fc region.
Public/Granted literature
- US20200085915A1 METHODS OF INDUCING IMMUNE TOLERANCE TO CLOTTING FACTORS Public/Granted day:2020-03-19
Information query
IPC分类:
